11 results
-
List item
Human medicine European public assessment report (EPAR): Xarelto
rivaroxaban, Arthroplasty, Replacement; Venous Thromboembolism
Date of authorisation: 30/09/2008, Revision: 40, Authorised, Last updated: 02/08/2023 -
List item
Referral: Pseudoephedrine-containing medicinal products (updated)
pseudoephedrine, Article 31 referrals
Status: Under evaluation, Last updated: 29/09/2023 -
List item
Referral: Ibuprofen- and dexibuprofen-containing medicines
ibuprofen, dexibuprofen, Article 31 referrals
Status: CMDh final position, opinion/position date: 20/05/2015, Last updated: 14/07/2015 -
List item
Orphan designation: hydrocortisone for: Treatment of adrenal insufficiency
Date of designation: 22/05/2006, Expired, Last updated: 25/11/2021 -
List item
Orphan designation: hydrocortisone for: Treatment of congenital adrenal hyperplasia
Date of designation: 27/07/2005, Positive, Last updated: 14/06/2021 -
List item
Orphan designation: dexamethasone for: Treatment of multiple myeloma
Date of designation: 09/06/2010, Withdrawn, Last updated: 12/02/2018kezelése Italian Desametasone (compressa da 40 mg) Trattamento del … -
List item
Press release: European Medicines Agency review concludes positive benefit-risk balance for non-selective NSAIDs
CHMP, Last updated: 24/10/2006 -
List item
Article 5(3) opinions on any scientific matter: human medicines
Last updated: 22/06/2023 -
List item
Public data from Article 57 database
Last updated: 30/06/2023 -
List item
Guidance documents
Last updated: 19/07/2022 -
List item
CHMP: meeting archive 2001-2009
Last updated: 18/11/2013